High levels of soluble programmed death-1 are associated with virological response in chronic hepatitis B patients after antiviral treatment

乙型肝炎表面抗原 恩替卡韦 免疫系统 乙型肝炎 医学 内科学 接收机工作特性 抗原 病毒 慢性肝炎 乙型肝炎病毒 免疫学 胃肠病学 拉米夫定
作者
Ning Tan,Hao Luo,Qian Kang,Jiali Pan,Ran Cheng,Hongli Xi,Hongyu Chen,Yanxi Han,Yuqing Yang,Xiaoyuan Xu
出处
期刊:Virus Research [Elsevier BV]
卷期号:309: 198660-198660 被引量:4
标识
DOI:10.1016/j.virusres.2021.198660
摘要

Soluble programmed cell death protein-1 (sPD-1) plays an important role in chronic hepatitis B virus (HBV) infection by counteracting the inhibitory effect of programmed death ligand-1 (PD-L1) on immune cells. Here, we investigated the ability of sPD-1 to predict the virological response (VR) in chronic hepatitis B (CHB) patients undergoing Nucleos(t)ide analogue (NA) therapy.CHB patients [hepatitis B surface antigen (HBsAg) positive ≥6 months] who initiated NA therapy in March 2007 at Peking University First Hospital (China) were enrolled in this study. Eighty-nine CHB patients were followed-up every 12 weeks for 96 weeks.Serum sPD-1 levels at baseline were negatively correlated with hepatitis B surface antigen (HBsAg) and HBV DNA. Immune-active CHB patients exhibited higher serum sPD-1 levels at baseline. Patients with VR during the antiviral treatment exhibited higher sPD-1 levels and lower HBsAg levels at baseline. Receiver operating characteristic (ROC) curves were generated to determine the predictive value of sPD-1 and HBsAg for VR in patients who received first-line therapy (entecavir, ETV). The area under ROC (AUROC) values of sPD-1 and HBsAg at baseline were 0.850 (95%CI:0.729-0.971, P = 0.0005) and 0.785 (95%CI: 0.642-0.929, P = 0.005), respectively, and the optimal cut-off values were 459.46 pg/mL and 14,710 IU/mL, respectively. The combination of sPD-1 and HBsAg exhibited a higher AUROC value (0.870,95% CI: 0.748-0.983, P = 0.001) than did sPD-1 or HBsAg alone. In patients administered second-line therapy (lamivudine, LAM/adefovir divipoxil, ADV), baseline sPD-1 levels above 677.2 pg/mL were significantly associated with higher incidence of VR after 96 weeks of antiviral therapy. It is 7.956 times the level of ≤677.2 pg/mL.By combining sPD-1 and HBsAg, we obtained a biomarker significantly associated with VR in CHB patients. The sPD-1 levels could be used to screen out patients with poor prognosis of antiviral therapy.
最长约 10秒,即可获得该文献文件

科研通智能强力驱动
Strongly Powered by AbleSci AI
科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
自由灵安完成签到,获得积分10
刚刚
满意无极完成签到,获得积分10
刚刚
Lucas的应助被现代雪晴采纳,获得10
刚刚
SciGPT的应助被一颗杨桃采纳,获得10
刚刚
瑭皓发布了新的文献求助10
刚刚
1秒前
1秒前
1秒前
开飞机的舒克完成签到,获得积分10
1秒前
1秒前
1秒前
2秒前
molihuakai的应助被杰杰小杰采纳,获得10
2秒前
九命猫发布了新的文献求助10
2秒前
3秒前
木香清半夏完成签到,获得积分10
3秒前
王梦雨完成签到,获得积分20
3秒前
yangqiaozhe发布了新的文献求助10
3秒前
丘比特的应助被maxu采纳,获得10
3秒前
mm完成签到,获得积分20
4秒前
花落微凉完成签到,获得积分10
4秒前
5秒前
zsf完成签到,获得积分10
5秒前
5秒前
秋风的应助被瓜倭吃不采纳,获得10
5秒前
5秒前
z69823发布了新的文献求助10
5秒前
5秒前
SFF完成签到,获得积分20
6秒前
6秒前
lalalla发布了新的文献求助20
6秒前
大模型的应助被难过如之采纳,获得10
6秒前
灼灼发布了新的文献求助10
7秒前
DW的应助被执着依瑶采纳,获得15
7秒前
123123完成签到,获得积分10
7秒前
7秒前
Lzz完成签到,获得积分20
8秒前
英吉利25发布了新的文献求助30
8秒前
8秒前
kevinave发布了新的文献求助50
8秒前
高分求助中
(应助此贴封号)【重要!!请各用户(尤其是新用户)详细阅读】【科研通的精品贴汇总】 10000
拉伸高分子熔体中缠结行为的模拟和小角中子散射研究 1700
奈特基础组织学:配套组织病理学(第4版)(Netter's Essential Histology With Correlated Histopathology) 800
John McDowells Bildungstheorie 800
八旗制度の研究 600
plantTFDB 508
Resource Recovery Handbook 500
热门求助领域 (近24小时)
化学 材料科学 医学 生物 纳米技术 计算机科学 工程类 有机化学 化学工程 生物化学 物理 复合材料 内科学 催化作用 光电子学 人工智能 细胞生物学 无机化学 物理化学 数学
热门帖子
关注 科研通微信公众号,转发送积分 8175556
求助须知:如何正确求助?哪些是违规求助? 9567240
关于积分的说明 21791502
捐赠科研通 7770174
什么是DOI,文献DOI怎么找? 3431868
关于科研通互助平台的介绍 2556244
邀请新用户注册赠送积分活动 2477299